Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

Clinical trial NCT06971939 · RECRUITING

Trial details

NCT number: NCT06971939
Sponsor: Neurotech Pharmaceuticals
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Macular Telangiectasia Type 2 (MacTel)

Start date: 2025-11-21
Primary completion: 2032-01-15
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.